| NCT ID | NCT01620372 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Institut National de la Santé Et de la Recherche Médicale, France |
| Condition | Childhood Solid Tumor |
| Study Type | OBSERVATIONAL |
| Enrollment | 18,000 participants |
| Start Date | 2011-11 |
| Primary Completion | 2031-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 18,000 participants in total. It began in 2011-11 with a primary completion date of 2031-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The FCCSS is a multicentric national large-scale collaborative population-based study of children treated for a solid tumor before 2000 in France and before the age of 19 years. The study is concerned by improving knowledge about the long-term effects caused by cancer and its treatments including adverse health and social outcomes. The main reason of the FCCSS is to estimate the risk of adverse health and social outcomes that may occur after a cancer treatment and to prevent them by providing adapted follow-up care. The cohort will be followed for up to 20 years from 2011.
Eligibility Criteria
Inclusion Criteria: * All types of solid childhood cancer in France * Age at diagnosis: Below age 19 * Period of diagnosis: between 1st January 1942 and 31st December 1999 * Complete identification (first name, last name, date of birth and place of birth) Exclusion Criteria: * Leukaemia cases
Contact & Investigator
Florent F. de Vathaire, Ph.D
✉ florent.devathaire@igr.frFlorent F. de Vathaire, Ph.D.
PRINCIPAL INVESTIGATOR
Institut National de la Santé Et de la Recherche Médicale, France
Frequently Asked Questions
Who can join the NCT01620372 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Childhood Solid Tumor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT01620372 currently recruiting?
Yes, NCT01620372 is actively recruiting participants. Contact the research team at florent.devathaire@igr.fr for enrollment information.
Where is the NCT01620372 trial being conducted?
This trial is being conducted at Amiens, France, Angers, France, Besançon, France, Bordeaux, France and 11 additional locations.
Who is sponsoring the NCT01620372 clinical trial?
NCT01620372 is sponsored by Institut National de la Santé Et de la Recherche Médicale, France. The principal investigator is Florent F. de Vathaire, Ph.D. at Institut National de la Santé Et de la Recherche Médicale, France. The trial plans to enroll 18,000 participants.